Eunyoung Tak
Overview
Explore the profile of Eunyoung Tak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwon J, Jwa E, Lee J, Tak E, Hwang S
Sci Rep
. 2025 Mar;
15(1):8654.
PMID: 40082572
Compared to overall survival, conditional survival is a more relevant measure of prognosis in surviving patients over time. This study developed and validated a nomogram-based dynamic prognostic model to predict...
2.
Lee R, Choi J, Lee E, Lee J, Kim J, Kang S, et al.
PeerJ
. 2024 Dec;
12:e18651.
PMID: 39655328
Background & Aims: The global pandemic caused by the highly contagious SARS-CoV-2 virus led to the emergency approval of COVID-19 vaccines to reduce rising morbidity and mortality. However, limited research...
3.
Czopik A, McNamee E, Vaughn V, Huang X, Bang I, Clark T, et al.
Nat Commun
. 2024 Sep;
15(1):8042.
PMID: 39271652
Metabolic imbalance leading to inflammatory hypoxia and stabilization of hypoxia-inducible transcription factors (HIFs) is a hallmark of inflammatory bowel diseases. We hypothesize that HIF could be stabilized in CD4 T...
4.
Choi J, Kang S, An H, Kim C, Lee S, Pack C, et al.
Stem Cell Res Ther
. 2024 Jul;
15(1):229.
PMID: 39075621
Background: Human mesenchymal stem cells originating from umbilical cord matrix are a promising therapeutic resource, and their differentiated cells are spotlighted as a tissue regeneration treatment. However, there are limitations...
5.
Lee J, Kim J, Lee R, Lee E, An H, Kwon Y, et al.
J Cell Mol Med
. 2024 Jul;
28(14):e18533.
PMID: 39034442
Hepatitis B Virus (HBV) infection significantly elevates the risk of hepatocellular carcinoma (HCC), with the HBV X protein (HBx) playing a crucial role in cancer progression. Sorafenib, the primary therapy...
6.
Yoo H, Yi Y, Kang Y, Kim S, Yoon Y, Tran P, et al.
Mol Cells
. 2023 Nov;
46(11):688-699.
PMID: 37968983
We set up this study to understand the underlying mechanisms of reduced ceramides on immune cells in acute rejection (AR). The concentrations of ceramides and sphingomyelins were measured in the...
7.
Lim S, Yoon Y, Kim J, Tak E, Kwon H, Shin S, et al.
Korean J Transplant
. 2023 Apr;
37(1):49-56.
PMID: 37064770
Background: Solid organ transplant recipients exhibit decreased antibody responses, mainly due to their weakened immune systems. However, data are limited on antibody responses after the primary series of coronavirus disease...
8.
Kang Y, Han M, Kim M, Hwang H, Ahn B, Tak E, et al.
Anticancer Res
. 2022 Dec;
43(1):63-73.
PMID: 36585162
Background/aim: We previously showed that human hepatic intrasinusoidal (HI) natural killer (NK) T cells selectively eliminate hepatocellular carcinoma (HCC) cell lines. In this study, we investigated the underlying mechanisms on...
9.
Namgoong J, Ageel A, Hwang S, Ha T, Song G, Jung D, et al.
Pediatr Transplant
. 2022 Oct;
27(1):e14416.
PMID: 36261859
Backgrounds: The anatomy of the left hepatic vein (LHV) is variable; thus, it should be considered for graft hepatic vein (GHV) venoplasty for left lateral section (LLS) and left liver...
10.
Lee J, Kim J, Lee R, Lee E, Choi T, Lee A, et al.
Biomed Pharmacother
. 2022 Oct;
156:113764.
PMID: 36228367
In the liver, reactive oxygen species (ROS) are constantly released during cellular metabolic processes, and excess ROS production can cause redox stress. The redox stress is both beneficial for and...